Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines

The article discusses the 2022 updated version of the collaborative ASAS/EULAR (Assessment in SpondyloArthritis international Society/European Alliance of Associations for Rheumatology) recommendations for the treatment of axial spondyloarthritis.

Saved in:
Bibliographic Details
Main Authors: Sh. F. Erdes, T. V. Dubinina
Format: Article
Language:Russian
Published: IMA PRESS LLC 2025-05-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/3722
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849687921496424448
author Sh. F. Erdes
T. V. Dubinina
author_facet Sh. F. Erdes
T. V. Dubinina
author_sort Sh. F. Erdes
collection DOAJ
description The article discusses the 2022 updated version of the collaborative ASAS/EULAR (Assessment in SpondyloArthritis international Society/European Alliance of Associations for Rheumatology) recommendations for the treatment of axial spondyloarthritis.
format Article
id doaj-art-08704a8ef8b14d17a49c7625ddfdec39
institution DOAJ
issn 1995-4484
1995-4492
language Russian
publishDate 2025-05-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-08704a8ef8b14d17a49c7625ddfdec392025-08-20T03:22:12ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922025-05-0163212913710.47360/1995-4484-2025-129-1373054Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelinesSh. F. Erdes0T. V. Dubinina1V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyThe article discusses the 2022 updated version of the collaborative ASAS/EULAR (Assessment in SpondyloArthritis international Society/European Alliance of Associations for Rheumatology) recommendations for the treatment of axial spondyloarthritis.https://rsp.mediar-press.net/rsp/article/view/3722clinical guidelinesaxial spondyloarthritisbiological therapyinhibitors of tumor necrosis factor alphainterleukin 17 inhibitorsjanus kinase inhibitors
spellingShingle Sh. F. Erdes
T. V. Dubinina
Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines
Научно-практическая ревматология
clinical guidelines
axial spondyloarthritis
biological therapy
inhibitors of tumor necrosis factor alpha
interleukin 17 inhibitors
janus kinase inhibitors
title Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines
title_full Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines
title_fullStr Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines
title_full_unstemmed Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines
title_short Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines
title_sort recommendations for the treatment of axial spondyloarthritis an analysis of the updated asas eular 2022 clinical guidelines
topic clinical guidelines
axial spondyloarthritis
biological therapy
inhibitors of tumor necrosis factor alpha
interleukin 17 inhibitors
janus kinase inhibitors
url https://rsp.mediar-press.net/rsp/article/view/3722
work_keys_str_mv AT shferdes recommendationsforthetreatmentofaxialspondyloarthritisananalysisoftheupdatedasaseular2022clinicalguidelines
AT tvdubinina recommendationsforthetreatmentofaxialspondyloarthritisananalysisoftheupdatedasaseular2022clinicalguidelines